CCPM
ASMB icon

Cooper Creek Partners Management’s Assembly Biosciences ASMB Stock Holding History

Cooper Creek Partners Management’s Portfolio ASMB Stock Details ASMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-19,848
Closed -$2.34M – 88
2019
Q3 		$2.34M Buy
+19,848
New +$3M 0.82% 57

Other funds holding ASMB

EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Cooper Creek Partners Management's ASMB Position: Q4 2019 in Review

Cooper Creek Partners Management sold out of Assembly Biosciences (ASMB) in Q4 2019, closing a stake of 19,848 shares — an estimated $2.34M sold.

Cooper Creek Partners Management first reported a position in ASMB in Q3 2019 and held it in 1 quarter. The position peaked at $2.34M in Q3 2019. 100 funds tracked by Wall St. Rank hold ASMB as of Q4 2019.

  • Cooper Creek Partners Management reported no remaining Assembly Biosciences position as of Q4 2019 after selling out during the quarter.
  • Cooper Creek Partners Management sold 19,848 Assembly Biosciences shares in Q4 2019, an estimated $2.34M.
  • Cooper Creek Partners Management first reported a position in Assembly Biosciences in Q3 2019 and held it in 1 quarter.
  • Cooper Creek Partners Management's Assembly Biosciences position peaked at $2.34M in Q3 2019.
  • 100 funds tracked by Wall St. Rank held Assembly Biosciences as of Q4 2019.

Based on Cooper Creek Partners Management's 13F filing for Q4 2019, filed 13 Feb 2020.